Technical Intelligence & Insights
Dive into our comprehensive technical reports covering the Pharma Healthcare sector. We analyze novel patents, catalytic processes, and cost-reduction strategies to streamline your commercial manufacturing.
Patent CN119264106B reveals high-purity chiral synthesis. Significant supply chain and cost advantages for pharmaceutical intermediates manufacturing partners globally.
Patent CN1929852A enables scalable α-PGG production without chromatography. Reduces cost and improves supply chain reliability for pharmaceutical intermediates.
Advanced preparation method for Gefarnate using mild Wittig chemistry. Enhances purity and yield for pharmaceutical intermediates while reducing industrial processing costs.
Novel chemical synthesis route for Phosphoramidon intermediates offers high yield and purity. Ideal for biochemical research supply chains requiring scalable and cost-effective manufacturing solutions.
Patent CN110643670A details a high-yield chemoenzymatic route for D-glutamine production, offering significant cost reduction in pharmaceutical manufacturing and scalable supply solutions.
Patent CN101747390B details a high-yield route for edaravone glucuronide, offering significant cost reduction in API manufacturing and improved purity.
Patent CN101565399A reveals a streamlined 5-step route improving yield to 27% and purity >99%, offering significant supply chain advantages.
Patent CN108341775B reveals a streamlined Minisci reaction for Rebamipide intermediates, offering significant cost reduction and simplified supply chain management for pharmaceutical manufacturers.
Advanced patent CN1024347C details a robust synthesis for aldose reductase inhibitors. Discover cost-effective manufacturing and high-purity supply chain solutions.
Patent CN103304659B reveals advanced solid-phase synthesis for Liraglutide. Enhances purity and yield for reliable pharmaceutical intermediate supply chains.
Patent CN114222734B reveals copper-catalyzed route for chromanone derivatives offering high purity and cost efficiency for pharmaceutical intermediates manufacturing supply chains.
Patent CN114276355B reveals microchannel reactor technology enhancing ibrutinib purity and yield for cost reduction in API manufacturing supply chains.
Novel one-pot copper-catalyzed route offers high purity and cost efficiency for pharmaceutical intermediates manufacturing supply chain reliability and scalability for global partners.
Novel NMP-based condensation route for TAF intermediate offers high yield, reduced solvent use, and scalable manufacturing for global supply chains.
Novel one-pot synthesis reduces cost and improves purity for minodronic acid manufacturing ensuring supply chain reliability and operational safety for global pharmaceutical partners.
Novel podophyllotoxin-quinine splice technology offers high yield and potent anti-tumor activity for pharmaceutical manufacturing supply chains and reliable sourcing.
Novel formic acid solvent method boosts yield for coptisine halide salt production ensuring cost efficiency and supply reliability for pharmaceutical partners.
Patent CN114315729A details a novel Suzuki coupling route for 1-benzyl-2,4-diarylimidazoles. This method offers superior regioselectivity and antitumor activity for reliable pharmaceutical intermediate supply.
Novel nickel-copper catalytic method for benzyl esters. Reduces costs and improves supply chain reliability for pharmaceutical intermediate manufacturing globally.
Patent CN104232696B enables high ee biocatalysis for pharmaceutical intermediates with significant cost and supply chain advantages for global buyers.